Respiratory Tract Diseases (Respiratory Tract Disease)

03/01/2013 - "The aim of this study was to compare the clinical and microbial efficacy of a 7-day or a 14-day course of doxycycline for the treatment of Mycoplasma felis-infected cats with clinical signs of upper respiratory tract disease (URTD) assessed using clinical scoring criteria. "
08/12/1973 - "[The use of doxycycline (vibramycin) in thoracic surgery and respiratory tract diseases]."
06/05/1971 - "[Experience with vibramycin in respiratory tract diseases, with special reference to bronchitis therapy]."
09/01/1970 - "[Use of rondomycin and vibramycin in respiratory tract diseases in children]."
01/01/2008 - "Upper respiratory tract disease (URTD) of cats is caused by a number of pathogens, including Chlamydophila felis and Mycoplasma spp. For effective treatment of both infections, doxycycline and enrofloxacin are recommended, but adverse effects limit their use in cats. "

10/01/2005 - "Diffuse panbronchiolitis (DPB) is a chronic, potentially life-threatening lower respiratory tract disease that is particularly common in Japanese people. "
06/01/2004 - "Diffuse panbronchiolitis is a new respiratory tract disease and was initially found in Japan. "
01/01/2001 - "Diffuse panbronchiolitis (DPB) is a chronic, potentially life-threatening lower respiratory tract disease that is particularly common in Japanese people. "
10/01/1994 - "The efficacy of low dose long-term erythromycin (EM) therapy in the treatment of chronic lower respiratory tract disease, including diffuse panbronchiolitis (DPB), has been reported, but its therapeutic mechanism is still unclear. "
01/01/1994 - "We demonstrated the efficacy of "long term" roxithromycin (RXM) treatment in 15 patients with chronic lower respiratory tract disease (11 with diffuse panbronchiolitis and 4 with sinobronchial syndrome). "

01/01/1995 - "Effect of roxithromycin on peripheral neutrophil adhesion molecules in patients with chronic lower respiratory tract disease."
01/01/1994 - "[Roxithromycin treatment in patients with chronic lower respiratory tract disease--its clinical efficacy and effect on cytokine]."
01/01/1994 - "We demonstrated the efficacy of "long term" roxithromycin (RXM) treatment in 15 patients with chronic lower respiratory tract disease (11 with diffuse panbronchiolitis and 4 with sinobronchial syndrome). "
09/01/2005 - "Roxithromycin (RXM) is a macrolide antibiotic that is effective in treatment of chronic lower respiratory tract diseases including diffuse panbronchiolitis and bronchial asthma. "
01/01/1995 - "To evaluate the effects of roxithromycin in patients with chronic lower respiratory tract disease including diffuse panbronchiolitis, we studied lymphocyte function-associated antigen-1 (LFA-1) and Mac-1, neutrophil adhesion molecules, using peripheral neutrophils from healthy volunteers and from patients with chronic lower respiratory tract disease. "

01/15/1993 - "Prophylactic efficacy of tilmicosin for bovine respiratory tract disease."
05/01/2000 - "In 2 separate studies of outbreaks, calves (study 1, n = 101; study 2, n = 105) that developed respiratory tract disease after transport to a feedlot were treated with tilmicosin. "
12/01/2000 - "Because tilmicosin inhibits the growth of MH in the respiratory tract, medication with tilmicosin prior to transport should reduce the incidence of acute respiratory tract disease during the first week at the feedlot when calves are most susceptible to infectious organisms."
05/01/2000 - "By reducing colonization, prophylactic use of tilmicosin before transport or at the time of arrival at a feedlot is likely to reduce the incidence of acute respiratory tract disease in calves for the initial several days after arrival, which is the period when they are most susceptible to infectious organisms."
05/01/2000 - "To determine the effect of tilmicosin treatment on number of Pasteurella haemolytica (PH) organisms in nasal secretion specimens of calves with respiratory tract disease. "

06/01/2013 - "Field study of the comparative efficacy of gamithromycin and tulathromycin for the control of undifferentiated bovine respiratory disease complex in beef feedlot calves at high risk of developing respiratory tract disease."

06/01/2013 - "Field study of the comparative efficacy of gamithromycin and tulathromycin for the control of undifferentiated bovine respiratory disease complex in beef feedlot calves at high risk of developing respiratory tract disease."

02/01/2007 - "In the upper respiratory tract disease trial, vedaprofen produced a significant reduction in rectal temperature when compared with cats administered antimicrobial treatment only. "
02/01/2007 - "The antipyretic and analgesic efficacy of vedaprofen (at a dose of 0.5 mg/kg) was evaluated after repeated once-daily administration (for three or five days) to 80 cats with upper respiratory tract disease or 302 cats undergoing ovariohysterectomy. "
02/01/2007 - "Vedaprofen produced a clinically relevant reduction in body temperature and a more rapid return to normality in cats with upper respiratory tract disease. "

05/01/1999 - "The doses of SB 209763 studied may have been insufficient to confer protection against RSV lower respiratory tract disease; these results suggest that additional trials using higher doses of monoclonal antibody for immunoprophylaxis should be considered."

03/01/1991 - "[Effect of erythromycin on neutrophil function in chronic respiratory tract diseases with Pseudomonas infection]."
10/01/1994 - "The efficacy of low dose long-term erythromycin (EM) therapy in the treatment of chronic lower respiratory tract disease, including diffuse panbronchiolitis (DPB), has been reported, but its therapeutic mechanism is still unclear. "
04/01/1997 - "However, low-dose and long-term 14 membered macrolide, such as erythromycin or clarithromycin, treatment has been reported as effective clinically in chronic lower respiratory tract disease. "
06/01/1996 - "We have recently reported that long-term administration of erythromycin at a low dose reduced the number of neutrophils and concentrations of interleukin 8 (IL-8) in bronchoalveolar lavage fluid in patients with chronic lower respiratory tract disease. "
01/01/1993 - "The mechanisms of erythromycin (EM) in chronic lower respiratory tract diseases including diffuse panbronchiolitis (DPB) has been reported. "

01/01/2000 - "Protection against respiratory tract disease was apparently associated with high level of opsonic and virus-neutralizing IgG2. "
08/01/1999 - "Local lymphoid tissues are the major production sites of IgG, which contributes to resistance to and recovery from respiratory tract diseases."
06/15/1996 - "Postcolostral total IgG values and antibody titers were not significantly different between cases and controls, implying that other factors have an important role in the development of respiratory tract disease."
07/01/1988 - "[IgG subclass distribution in selected patients with long-term and severe chronic obstructive respiratory tract disease]."
11/01/1987 - "However, by individualizing therapy for each patient, it is possible to prevent life-threatening acute infections, reduce the severity of chronic upper and lower respiratory tract disease, improve pulmonary function and achieve normal levels of IgG. These are the currently acceptable goals of therapy in patients with hypogammaglobulinemia."

01/01/1987 - "Nissen fundoplication cured GER in all cases, and its effect on respiratory tract disease after an average follow-up of 17 months (range 6 to 48) was rather encouraging: twenty-six children cured (57%), 9 improved (21%) and 10 remained unchanged (22%). "

04/15/1990 - "Study of the acceptance of the Ingelheim M inhaler in chronic obstructive respiratory tract diseases]."
11/01/2001 - "Most patients (82.8%) reported using their nebulizer for bronchopulmonary symptoms and the remaining patients only used theirs for upper respiratory tract diseases. "
11/01/1982 - "[Continuous use of nebulizers and their effects in chronic respiratory tract diseases]."

06/01/2010 - "12 tracheas obtained within 5 hours after euthanasia from horses free from respiratory tract disease. "
10/01/2009 - "For cats included in the study, data that were recorded included signalment, initial complaint, whether the cat had any clinical signs of middle or external ear disease, whether the cat had upper respiratory tract disease, necropsy diagnosis, gross appearance of the bullae, and reason for euthanasia. "
07/01/1986 - "All calves developed profuse diarrhea by PID 2 to 4; however, calves did not develop clinical signs of respiratory tract disease before euthanasia or death. "

01/01/1998 - "[The value of studies of quality of life in chronic respiratory tract diseases in the framework of holistic medicine]."

04/15/2014 - "Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease."
04/15/2014 - "Respiratory syncytial virus (RSV) lower respiratory tract disease (LRD) is a life-threatening complication in hematopoietic cell transplant (HCT) recipients. "
04/15/2014 - "Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease."
06/01/2010 - "Fatal lower respiratory tract disease with human corona virus NL63 in an adult haematopoietic cell transplant recipient."
05/01/2014 - "Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcome."